• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 780
  • 136
  • 113
  • 107
  • 50
  • 38
  • 20
  • 19
  • 14
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • Tagged with
  • 1612
  • 1612
  • 253
  • 249
  • 196
  • 168
  • 149
  • 135
  • 132
  • 129
  • 121
  • 103
  • 94
  • 90
  • 88
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
271

A study into the potential benefits of essential fatty acid supplementation in the cognitively impaired

Phillips, Michelle Anne January 2009 (has links)
No description available.
272

Early Growth Response 2 (Egr2) Induction by Neuronal Activity-dependent Nuclear Factor Kappa B (NF-κB) Activation

Nafez, Solmaz 13 September 2010 (has links)
Nuclear factor kappa B (NF-κB) mediated signalling is complex and plays a critical role in many biological processes. Investigators have reported that NF-κB is activated during the induction of long term potentiation (LTP), a proposed mechanism for memory encoding, and may be a requirement for synaptic plasticity and memory. In this study, mRNA extracted from hippocampal slices of NF-kB p50 knockout mice and its littermate before and after induction of LTP was analyzed using DNA microarray analysis (Affy-metrix GeneChip® Mouse Genome 430 2.0) to explore candidate target genes of NF-kB in LTP. The early growth response 2 (Egr-2) was identified as one putative NF-kB target gene. Egr-2 mRNA and protein analysis of primary cortical neurons and HeLa cells chemically stimulated with Tumor Necrosis Factor α (TNFα) to activate the NF-kB sig-nalling pathway confirmed the microarray results. In addition, examination of the Egr-2 promoter sequence for NF-kB binding sites using chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assays (EMSA) confirmed promoter occupancy and specificity of binding in vivo, respectively. These data suggest that Egr-2 expression level is controlled by direct transcriptional activity of the NF-kB transcription factor.
273

The effects of sensory stimulation activities on the psychological well-being of advanced Alzheimer patients

Witucki, Janet January 1994 (has links)
There is an absence of nursing studies that explore interventions to enhance psychological well-being for advanced Alzheimer patients. While sensory stimulation has been identified as a nursing intervention for dementia patients. Few studies reporting the effects of such interventions for patients with late stage dementia are available. The purpose of this study was to examine the effects of sensory stimulation activities on the psychological wellbeing of advanced Alzheimer patients. The conceptual model of “the good life” developed by Lawton (1983) provided the framework for this study. A descriptive design with a single group and pre-test post-test repeated measures analysis of variance was used for this study.A convenience sample of 15 patients from three Midwest long-term care facilities was observed for the effects of music. Touch and smell on psychological well-being as measured by the Discomfort Scale for Dementias of the Alzheimer Type (DS-DAT) (Hurley, Volicer, Hanrahan, Houde & Volicer, 1992). The rights of patients were protected at all times, with legal guardians receiving a written explanation of the study. Actual stimulation activities were conducted by Activity Directors or assistants from each facility.Paired t-test analysis of data revealed that DS-DAT scores for all three stimulation activities were significantly lower at <.05 level of significance than baseline DS-DAT scores. Lower DS-DAT scores included more positive affect behaviors and fewer negative affect behavior. A conclusion was drawn that the three sensory stimulation activities increased psychological well-being in the advanced Alzheimer patient sample. This study was significant because findings will support rationale for education of nursing staff in sensory stimulation procedures and provide information on evaluation of intervention outcomes for advanced Alzheimer patients. / School of Nursing
274

The long road into darkness : the effect of education on the rate-of-decline of Alzheimer’s patients / Title on signature form: Long into darkness : the effect of education on the rate-of-decline of Alzheimer’s patients

Predina, Leslie A. 06 July 2011 (has links)
Access to abstract permanently restricted to Ball State community only / Access to thesis permanently restricted to Ball State community only / Department of Educational Psychology
275

Apolipoprotein E Isoforms Differentially Regulate Amyloid-β Stimulated Inflammation in Rat and Mouse Astrocytes

Dorey, Evan J 07 December 2012 (has links)
Neuroinflammation occurs in Alzheimer’s disease (AD) brain, and plays a role in neurodegeneration. The main aim of this study was to determine how treatments with exogenous apolipoprotein E (ApoE2, E3 and E4 isoforms), a genetic risk factor for AD, affects the amyloid-β (Aβ) induced inflammatory response in vitro in astrocytes. Recombinant, lipid-free ApoE4 was found not to affect Aβ-induced inflammation in rat astrocytes, while ApoE2 showed a protective effect. Mouse cells expressing human ApoE isoforms, which have similar lipidation and modification to native human ApoE, showed ApoE4 promoting inflammation, and no ApoE2 protective effect upon Aβ treatment. A Protein/DNA array was used to screen 345 transcription factors in rat astrocytes treated with Aβ and/or ApoE isoforms, in order to determine which contribute to the observed ApoE2 protection. Some candidates were validated by Western Blot or EMSA and/or by inhibition or activation. The findings suggest ApoE isoforms differentially regulate Aβ-induced inflammation, and multiple signalling pathways are involved in the process.
276

Early Growth Response 2 (Egr2) Induction by Neuronal Activity-dependent Nuclear Factor Kappa B (NF-κB) Activation

Nafez, Solmaz 13 September 2010 (has links)
Nuclear factor kappa B (NF-κB) mediated signalling is complex and plays a critical role in many biological processes. Investigators have reported that NF-κB is activated during the induction of long term potentiation (LTP), a proposed mechanism for memory encoding, and may be a requirement for synaptic plasticity and memory. In this study, mRNA extracted from hippocampal slices of NF-kB p50 knockout mice and its littermate before and after induction of LTP was analyzed using DNA microarray analysis (Affy-metrix GeneChip® Mouse Genome 430 2.0) to explore candidate target genes of NF-kB in LTP. The early growth response 2 (Egr-2) was identified as one putative NF-kB target gene. Egr-2 mRNA and protein analysis of primary cortical neurons and HeLa cells chemically stimulated with Tumor Necrosis Factor α (TNFα) to activate the NF-kB sig-nalling pathway confirmed the microarray results. In addition, examination of the Egr-2 promoter sequence for NF-kB binding sites using chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assays (EMSA) confirmed promoter occupancy and specificity of binding in vivo, respectively. These data suggest that Egr-2 expression level is controlled by direct transcriptional activity of the NF-kB transcription factor.
277

α-Secretase processing of the Alzheimer amyloid-β precursor protein and its homolog APLP2

Jacobsen, Kristin January 2013 (has links)
The amyloid-β precursor protein (APP) has been widely studied due to its role in Alzheimer´s disease (AD). When APP is sequentially cleaved by β- and γ-secretase, amyloid-β (Aβ) is formed. Aβ is prone to aggregate and is toxic to neurons. However, the main processing pathway for APP involves initial cleavage at the α-site, within the Aβ region, instead generating a neuroprotective soluble fragment, sAPPα. APP is a member of a protein family, also including the proteins APLP1 and APLP2, which are processed in a similar way as APP. In addition, K/O studies in mice have shown that the three proteins have overlapping functions where APLP2 play a key physiological role. The aim of this thesis was to study mechanisms underlying the α-secretase processing of APP and APLP2. We have used the human neuroblastoma cell-line SH-SY5Y as a model system and stimulated α-secretase processing with insulin-like growth factor-1 (IGF-1) or retinoic acid (RA). Our results show that the stimulated α-site cleavage of APP and APLP2 is regulated by different signaling pathways and that the cleavage is mediated by different enzymes. APP was shown to be cleaved by ADAM10 in a PI3K-dependent manner, whereas APLP2 was cleaved by TACE in a PKC-dependent manner. We further show that protein levels and maturation of ADAM10 and TACE is increased in response to RA, mediated by a PI3K- or PKC-dependent signaling pathway, respectively. Another focus of our research has been O-GlcNAcylation, a dynamic post-translational modification regulated by the enzymes O-GlcNAc transferase and O-GlcNAcase (OGA). We show that decreased OGA activity stimulates sAPPα secretion, without affecting APLP2 processing. We further show that ADAM10 is O-GlcNAcylated. Lastly, we show that APP can be manipulated to be cleaved in a similar way as APLP2 during IGF-1 stimulation by substituting the E1 domain in APP with the E1 domain in APLP2. Together our results show distinct α-site processing mechanisms of APP and APLP2. / <p>At the time of the doctoral defence the following papers were unpublished and had a status as follows: Paper 4: Manuscript; Paper 5: Manuscript.</p>
278

A convergent approach to huperzine A

Caprio, Vittorio January 1997 (has links)
No description available.
279

Subcortical Hyperintensities in Alzheimer's Disease and the Elderly: An MRI-based Study Examining Signs of Cerebrovascular Disease and Dementia

Ramirez, Joel Roy 19 December 2012 (has links)
Subcortical hyperintensities (SH) are believed to be observable signs of cerebrovascular disease, indicating some form of subcortical vasculopathy. Also commonly referred to as leukoariosis, these hyperintense signals on proton density, T2-weighted and fluid attenuated inversion recovery magnetic resonance images, are commonly observed phenomena in Alzheimer’s disease patients and elderly persons. Several SH sub-types with differential brain-behavior associations have been proposed in the scientific literature: periventricular, deep white, cystic fluid filled lacunar-like infarcts and perivascular Virchow-Robin spaces. This study will present Lesion Explorer (LE): a comprehensive tri-feature MRI-based processing pipeline that effectively and reliably quantifies SH sub-types in the context of additional brain tissues volumetrics in a regionalized manner. The LE pipeline was validated using a scan-rescan procedure. Finally, the LE pipeline was applied in a cross-sectional study of Alzheimer’s disease patients and normal elderly controls. Brain-behavior relationships were demonstrated with regional SH volumes and executive functioning, speed of mental processing, and verbal memory.
280

Rational Design of sym-Triazines For Multitarget-directed Modulation of Cholinesterases and Amyloid-beta in Alzheimer’s Disease

Dhar, Devjani 11 July 2013 (has links)
Alzheimer’s disease (AD), a progressive age-related neurodegenerative disorder is characterized by impairments in memory and cognitive functions. The two main pathogenic hallmarks associated with the progression of this multifactorial disease include accumulation of amyloid-beta (Aβ) plaques and the deterioration of the cholinergic system in the brain. Using cost-effective synthetic procedures, mono-, di-, and tri- substituted sym-triazine derivatives incorporating acetylcholine substrate analogues and aromatic phenyl moieties were synthesized for the targeted modulation of Aβ aggregation and acetylcholinesterase (AChE) activity. A subset of these sym-triazines demonstrated dual inhibition of Aβ fibrillization and AChE hydrolytic activity in vitro studies. These highly effective compounds were also shown to be well tolerated by differentiated human neuronal cells in cell viability tests. These novel compounds have the potential to undergo future in vivo pharmaceutical analysis and have a positive impact on the quality of life of the people living with this devastating disease and their caretakers.

Page generated in 0.0638 seconds